High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma

スポンサーリンク

概要

• 論文の詳細を見る
• 1997-07-01

著者

• ITOH Kyogo

  Departments of Immunology, Kurume University School of Medicine

• Sakata M

  Division Of Gastroenterology Department Of Medicine Kurume University School Of Medicine

• Sata Michio

  京都府立医科大学 消化器内科学

• Sata Michio

  大腸肛門病センターくるめ病院

• SATA Michio

  Second Department of Internal Medicine, Kurume University

• Tanikawa K

  Division Of Gastroenterology Department Of Medicine Kurume University School Of Medicine

• Sata Michio

  久留米大学 医学部消化器内科部門

• Sata Michio

  久留米大学 消化器内科

• TANIKAWA Kyuichi

  Second Department of Medicine, Kurume University School of Medicine

• Chiba Itsuo

  First Department Of Oral Surgery Hokkaido University School Of Dentistry

• Itoh K

  Kurume Univ. School Of Medicine Fukuoka Jpn

• KOMIYAMA Kazuo

  Department of Pathology, Nihon University School of Dentistry

• Komiyama Kazuo

  Department Of Oral And Maxillofacial Surgery Nihon University School Of Dentistry

• Komiyama Kazuo

  Department Of Pathology Nihon University School Of Dentistry

• Tanikawa Kyuichi

  Second Department Of Internal Medicine Kurume University School Of Medicine

• Itoh Kyogo

  Department Of Immunology

• Murashima S

  Second Department Of Internal Medicine Kurume University School Of Medicine

• NAGAO Yumiko

  Department of Oral Surgery, Kurume University School of Medicine

• YANOMA Shunsuke

  Clinical Research Institute, Kanagawa Cancer Center

• EURA Masao

  Department of Otolaryngology, Kumamoto University School of Medicine

• KAMEYAMA Tadamitsu

  Department of Oral Surgery, Kurume University School of Medicine

• Eura Masao

  Department Of Otolaryngology Kumamoto University School Of Medicine

• Nagao Yumiko

  Department Of Oral Surgery Kurume University School Of Medicine

• Sata Michio

  Second Dep. Of Internal Medicine Kurume Univ. School Of Medicine

• Sata Michio

  Departments Of Internal Medicine Kurume University School Of Medicine

• Kawaguchi Takumi

  Department Of Digestive Disease Information & Research Kurume University School Of Medicine

• Nagao Yumiko

  久留米大学 口腔外科

• Kameyama Tadamitsu

  Department Of Oral And Maxillofacial Surgey Kurume University School Of Medicine

• Yanoma Shunsuke

  Clinical Research Institute Kanagawa Cancer Center

• Yanoma Shunsuke

  Clinicak Research Institute Kanagawa Cancer Center

• KAMEYAMA TADAMITSU

  Department of Dentistry and Oral Surgery, Kurume University School of Medicine

• NAGAO YUMIKO

  Department of Oral Surgery

• NAGAO Yumiko

  Department of Digestive Disease Information and Research, Kurume University School of Medicine

関連論文

• Analysis of tumor necrosis factor-α production and polymorphisms of the tumor necrosis factor-α gene in individuals with a history of Kawasaki disease
• Impaired gastric motility and its relationship to reflux symptoms in patients with nonerosive gastroesophageal reflux disease
• Peginterferon-alpha-2b plus ribavirin therapy in patients with chronic hepatitis C as assessed by a multi-institutional questionnaire in Japan
• Human primary cultured hepatic stellate cells can be cryopreserved
• High expression of insulin-like growth factor binding protein-3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma
• Case-control study for the identification of virological factors associated with fulminant hepatitis B
• Characterization of the light chain-restricted clonal B cells in peripheral blood of HCV-positive patients
• Supplement improves nutrition and stresses caused by examination-associated fasting in patients with liver cirrhosis
• Periostin and bone marrow fibrosis
• Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
• Keratin inclusions alter cytosolic protein localization in hepatocytes
• Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load
• Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b^+ HLA-A24^+ patients
• Impaired Filterability of Erythrocytes from Patients with Chronic Hepatitis C and Effects of Eicosapentaenoic Acid on the Filterability
• New Epitope Peptides Derived from Hepatitis C Virus (HCV) 2a Which Have the Capacity to Induce Cytotoxic T Lymphocytes in HLA-A2^+ HCV-Infected Patients
• Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report
• Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
• Liposome-mediated gene transfer of K1-5 suppresses tumor development and improves the prognosis of hepatocellular carcinoma in mice
• A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and C
• Angiogenic cell therapy for hepatic fibrosis
• Timing of interferon therapy and sources of infection in patients with acute hepatitis C
• Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment
• A human T-cell lymphotropic virus type-1 (HTLV-1) carrier complicated with various autoimmune diseases including primary biliary cirrhosis
• Combination chemotherapy with cisplatin and gemcitabine in malignant peritoneal mesothelioma
• Gastric phenotype signet-ring cell carcinoma of the stomach with multiple bone metastases effectively treated with sequential methotrexate and 5-fluorouracil
• Impact of daily high-dose IFNα-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels
• Prediction of treatment outcome with daily high-dose IFN α-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels : relationship of baseline viral levels and viral dynamics during and after therapy
• A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C : a multicenter, prospective, randomized, controlled trial in Japan
• Phase I trial of patient-oriented vaccination in HLA-A2-positive patients with metastatic hormone-refractory prostate cancer
• Unusual hyperbilirubinemia associated with bacterial pneumonia and acute myeloid leukemia
• Blastoid Variant of Mantle Cell Lymphoma with Lactic Acidosis : A Case Report
• Inflammatory myopathy associated with hepatitis C virus infection: a report of four cases
• Effect of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis C virus infection
• Impaired Gastric Motility in Patients with Functional Dyspepsia
• Improvement of gastric motility by hemodialysis in patients with chronic renal failure
• Effects of endothelin-1 on the membrane potential and slow waves in circular smooth muscle of rat gastric antrum
• Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C
• Sequence Analysis of Genes Encoding Rodent Homologues of the Human Tumor-rejection Antigen SART-1
• Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer
• Bronchiolitis obliterans organizing pneumonia in a patient with primary biliary cirrhosis and rheumatoid arthritis treated with prednisolone
• High prevalence of anticardiolipin antibodies in hepatitis C virus infection : lack of effects on thrombocytopenia and thrombotic complications
• Systemic Sclerosis Associated with Diabetes Insipidus
• ENDOSCOPIC RETRIEVAL OF MIGRATED PLASTIC STENT INTO BILE DUCT OR PANCREATIC PSEUDOCYST
• Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon
• GB virus C (GBV-C)/hepatitis G virus (HGV) infection in a hepatitis C virus hyper-endemic area in Japan
• Cytotoxicity Induced by Erythrina variegata Serine Proteinase Inhibitors in Tumor Hematopoietic Stem Cell Lines
• Interferon-γ brings additive anti-viral environment when combined with interferon-α in patients with chronic hepatitis C
• Antiphospholipid syndrome modifies the clinical features of systemic lupus erythematosus
• Personalized peptide vaccines : A new therapeutic modality for cancer
• Expression of Tumor-rejection Antigens in Gynecologic Cancers
• Expression of the SART-1 Antigens in Uterine Cancers
• Target molecules in specific immunotherapy against prostate cancer
• Identification of a prostate-specific membrane antigen-derived peptide capable of eliciting both cellular and humoral immune responses in HLA-A24^+ prostate cancer patients
• Expression of MAGE-1 Gene by Esophageal Carcinomas
• Histocompatibility Leukocyte Antigen-A2402-restricted Cytotoxic T Lymphocytes Recognizing Adenocarcinoma in Tumor-infiltrating Lymphocytes of Patients with Colon Cancer
• Expression of SART3 Tumor-rejection Antigen in Gastric Cancers
• Changes in the Mononuclear Cell Subpopulations of Rat Cardiac Transplant Recipients Administered FK506 for the Treatment of Ongoing Rejection
• Phase I trial of personalized peptide vaccination for cytokine-refractory metastatic renal cell carcinoma patients
• Antibody Reactive to a Hepatitis C Virus (HCV)-Derived Peptide Capable of Inducing HLA-A2 Restricted Cytotoxic T Lymphocytes Is Detectable in a Majority of HCV-Infected Individuals without HLA-A2 Restriction
• Chemohormonal therapy as primary treatment for metastatic prostate cancer : A randomized study of estramustine phosphate plus luteinizing hormone-releasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist
• Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide
• Immunological evaluation of CTL precursor-oriented vaccines for advanced lung cancer patients
• Serine Proteinase Inhibitor 9 Can Be Recognized by Cytotoxic T Lymphocytes of Epithelial Cancer Patients
• Identification of Cyclophilin B-derived Peptides Capable of Inducing Histocompatibility Leukocyte Antigen-A2-restricted and Tumor-specific Cytotoxic T Lymphocytes
• Detection of Circulating Tumor Cells in Patients with Prostate Cancer Using Prostate Specific Membrane-Derived Primers in the Polymerase Chain Reaction
• Spectroscopic Analysis of the Cytoagglutinating Activity of Abrin-b Isolated from Abrus precatorius Seeds against Leukemic Cells
• A GENE ENCODING SQUAMOUS CELL CARCINOMA ANTIGENS RECOGNIZED BY CYTOTOXIC T LYMPHOCYTE
• Genes Encoding Antigenic Peptides of Human Epithelial Cancers Recognized by Cytotoxic T Lymphocytes
• Detection of MAGE-4 Protein in Sera of Lung Cancer Patients
• Human Tumor Rejection Antigens MAGE1^1
• Cytokine Production by T Cells Infiltrating in the Eye of Uveitis Patients
• Induction of MAGE Genes in Lymphoid Cells by the Demethylating Agent 5-Aza-2'-deoxycytidine
• In Vitro Effects of Immunosuppressive Agents on Cytokine Production by HTLV-I-Infected T Cell Clones Derived from the Ocular Fluid of Patients with HTLV-I Uveitis
• Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanona antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease
• Involvement of GBV-C/HGV in liver diseases in Japan
• High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma
• Short term and two-step interferon therapy for chronic hepatitis C patients with low HCV RNA levels
• Dextromethorphan for neuropathic pain with Churg-Strauss syndrome
• Polyarteritis nodosa with mesenteric aneurysms demonstrated by angiography : report of a case and successful treatment of the patient with prednisolone and cyclophosphamide
• Pulse Intravenous Cyclophosphamide Treatment for Steroid-resistant Interstitial Pneumonitis Associated with Polymyositis
• Effects of OK-432 on matrix metalloproteinase-9 expression and activity in rat cultured Kupffer cells
• Clinical usefulness of serum HBV DNA measurement with a non radioactive chemiluminescence method
• A pilot study of natural interferon γ therapy for chronic hepatitis C
• Liver-Associated Natural Killer Activity in Cirrhotic Rats
• Characteristics of complete responders to interferon among patients with chronic hepatitis C with high serum levels of RNA
• Elevation of Serum MAGE-4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis
• Detection of MAGE-4 Protein in the Sera of Patients with Hepatitis-C Virus-associated Hepatocellular Carcinoma and Liver Cirrhosis
• Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles
• Gender difference in alcoholic liver desease in Japan-an analysis based on histological findings
• Identification of peptides applicable as vaccines for HLA-A26-positive cancer patients
• Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection
• A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis
• Recent progress in the management of hepatocellular carcinoma detected during a surveillance program in Japan
• Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C
• GENERAL RULES FOR RECORDING ENDOSCOPIC FINDINGS OF ESOPHAGOGASTRIC VARICES (2ND EDITION)
• Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD : a pilot study
• Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis
• Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection : decision-tree analysis
• Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1
• Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy

もっと見る 閉じる

スポンサーリンク